Does Mitotane need to be taken long-term?

Mitotane (Mitotane), as a drug for the treatment of adrenocortical cancer, usually needs to be taken for a long time, and may even need to be taken for life, depending on the patient's condition and treatment effect.

1.Long-term treatment: Because adrenocortical cancer is usually a malignant tumor and is often invasive and metastatic, treatment of adrenocortical cancer usually requires long-term treatment. Mitotane is often used as a first-line treatment as part of long-term treatment to control tumor growth and spread and prolong patient survival.

2.Maintenance treatment: For those patients whose tumors cannot be completely removed by surgery or have metastasized, Mitotane (mitotane) is often used for maintenance treatment, that is, as continued drug treatment after surgery, radiotherapy, or chemotherapy. This helps prevent tumor recurrence or progression and keeps the patient's condition under control.

3.Lifelong use: For some patients, mitotane may need to be taken for life. Although the cure rate of adrenocortical cancer is low, with continued treatment, the disease can be controlled, the patient's survival period can be prolonged, and the quality of life can be improved. Therefore, some patients whose disease is stable or whose tumors cannot be completely removed may need to take Mitotane for life.

4.Monitoring and adjusting treatment: During long-term usemitotane , patients need to be monitored and evaluated by their doctor regularly. The doctor will adjust the drug dosage or treatment plan according to the patient's condition and treatment effect to ensure the best treatment effect and minimal side effects.

In general, Mitotane , as a drug for the treatment of adrenocortical cancer, usually needs to be taken for a long time or even lifelong. During the course of taking it, patients need to receive regular monitoring and evaluation from doctors, and the treatment plan should be adjusted according to the doctor's recommendations to achieve the best treatment effect.